VentureMed Group Closes $28M Series C Funding Led by S3 Ventures to Accelerate Adoption of the FLEX VPTM System.

Oct 29, 2025•4 days ago

Amount Raised

$28 Million

Round Type

SERIES C

PlymouthHealth Care

Investors

Endeavour VisionS3 Ventures

Description

VentureMed Group, Inc. has secured $28 million in a Series C funding round led by S3 Ventures, with participation from existing investors like Endeavour Vision. This financing will enhance their commercial infrastructure and support new product development. The funds will advance the clinical program focusing on vascular care solutions

Company Information

Company

VentureMed Group

Location

2800 Campus Drive Suite 50

Plymouth, Minnesota, United States

About

VentureMed Group, Inc. is a pioneering medical device company dedicated to advancing endovascular solutions for arteriovenous (AV) access and peripheral arterial disease (PAD) interventions. The company's flagship technology, the FLEX Vessel Prep™ System, is designed to optimize vessel preparation using its proprietary Kinetic Endovascular Micro-incision Creation (KEMIC) technology. Unlike traditional balloon-based approaches that apply static pressure, KEMIC leverages-controlled motion and dynamic vessel apposition to create long, precise micro-incisions. As FLEX is pulled back through the vessel, the outward pressure of the struts ensures continuous contact with the vessel wall, while the pull-back motion of the blades generates a series of precise micro-incisions.

Related People

Funding Insights

Based on industry data

VC-backed spending patterns

VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

Tech investment trends